OXA-48-Like β-Lactamases: Global Epidemiology, Treatment Options, and Development Pipeline

Sara E. Boyd, Alison Holmes, Richard Peck, David M. Livermore, William Hope

Open source

DOI
10.1128/aac.00216-22
Published
2022-08-16
Container
Antimicrobial Agents and Chemotherapy
Publisher
American Society for Microbiology
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1128/aac.00216-22,
  title = {OXA-48-Like β-Lactamases: Global Epidemiology, Treatment Options, and Development Pipeline},
  author = {Sara E. Boyd and Alison Holmes and Richard Peck and David M. Livermore and William Hope},
  year = {2022},
  journal = {Antimicrobial Agents and Chemotherapy},
  doi = {10.1128/aac.00216-22},
  url = {https://doi.org/10.1128/aac.00216-22}
}

RIS

TY  - JOUR
TI  - OXA-48-Like β-Lactamases: Global Epidemiology, Treatment Options, and Development Pipeline
AU  - Sara E. Boyd
AU  - Alison Holmes
AU  - Richard Peck
AU  - David M. Livermore
AU  - William Hope
PY  - 2022
JO  - Antimicrobial Agents and Chemotherapy
DO  - 10.1128/aac.00216-22
UR  - https://doi.org/10.1128/aac.00216-22
ER  - 

APA

Boyd, S. E., Holmes, A., Peck, R., Livermore, D. M., & Hope, W. (2022). OXA-48-Like β-Lactamases: Global Epidemiology, Treatment Options, and Development Pipeline. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00216-22

Source records